AOTS yields 9.52% · JNJ yields 2.14%● Live data
📍 AOTS pulled ahead of the other in Year 1
Combined, AOTS + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AOTS + JNJ for your $10,000?
AOTS tracks an index of companies classified as software-driven enterprises, whose core business relies on software platforms and generates at least 20% of revenue from software-driven activities (cloud infrastructure, enterprise software, development tools, analytics/AI, middleware, industry solutions). Companies must have a positive Earnings to Price ratio to qualify. Selection is based on the average rank of a factor score (cost of goods sold/revenue, earnings/price, return on invested capital) and market cap, with the top 50 ranked firms and a 10-company buffer for incumbents. Weighting favors companies with over 50% software revenue, while those below are capped at 20%. Weights are float-adjusted, max 7.5%, min 0.5%, with over-5% weights keeping below 45% in total. The index is reconstituted and rebalanced on the third Friday of March, June, September, and December.
Full AOTS Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.